BioStem Technologies, Inc.
BSEM · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $10,473 | $49,296 | $72,528 | $102,874 |
| % Growth | -78.8% | -32% | -29.5% | – |
| Cost of Goods Sold | $1,262 | $685 | $853 | $3,591 |
| Gross Profit | $9,211 | $48,611 | $71,675 | $99,283 |
| % Margin | 87.9% | 98.6% | 98.8% | 96.5% |
| R&D Expenses | $1,958 | $1,957 | $1,690 | $1,273 |
| G&A Expenses | $0 | $6,872 | $6,997 | $8,266 |
| SG&A Expenses | $5,804 | $46,480 | $64,681 | $89,529 |
| Sales & Mktg Exp. | $0 | $39,608 | $57,684 | $81,322 |
| Other Operating Expenses | $0 | $61 | $54 | $0 |
| Operating Expenses | $7,762 | $48,499 | $66,425 | $90,801 |
| Operating Income | $1,449 | $113 | $5,249 | $8,482 |
| % Margin | 13.8% | 0.2% | 7.2% | 8.2% |
| Other Income/Exp. Net | $20 | $65 | $31 | -$63 |
| Pre-Tax Income | $1,469 | $178 | $5,281 | $8,418 |
| Tax Expense | $708 | $742 | $797 | -$7,102 |
| Net Income | $761 | -$564 | $4,483 | $15,520 |
| % Margin | 7.3% | -1.1% | 6.2% | 15.1% |
| EPS | 0.045 | -0.034 | 0.27 | 0.94 |
| % Growth | 234.3% | -112.5% | -71.3% | – |
| EPS Diluted | 0.03 | -0.034 | 0.17 | 0.68 |
| Weighted Avg Shares Out | 16,750 | 16,709 | 26,371 | 16,428 |
| Weighted Avg Shares Out Dil | 23,235 | 16,709 | 26,258 | 22,770 |
| Supplemental Information | – | – | – | – |
| Interest Income | $143 | $65 | $32 | $0 |
| Interest Expense | $0 | $0 | $0 | $66 |
| Depreciation & Amortization | $58 | $61 | $54 | $78 |
| EBITDA | $1,526 | $173 | $5,303 | $8,562 |
| % Margin | 14.6% | 0.4% | 7.3% | 8.3% |